Finance

Lists
524372:BOM
Orchid Pharma Ltd
₹1,103.65
-0.32%
(-3.55) 1D
Sep 23, 3:52:36 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524372...
Open
₹1,105.75
High
₹1,128.50
Low
₹1,094.00
Mkt. cap
65.51B
Avg. vol.
6.73K
Volume
10.37K
52-wk high
₹1,142.65
52-wk low
₹471.30
No. of employees
1K
Open
₹1,105.75
High
₹1,128.50
Low
₹1,094.00
Mkt. cap
65.51B
Avg. vol.
6.73K
Volume
10.37K
52-wk high
₹1,142.65
52-wk low
₹471.30
No. of employees
1K
Profile
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
About Orchid Pharma Ltd
CEO-
Employees1.46K
Founded1992
Headquarters-
SectorPharmaceutical industry
Websiteorchidpharma.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.94B
2.07B
3.68B
3.04B
Cost of goods sold
1.33B
1.43B
2.45B
2.04B
Cost of revenue
1.33B
1.43B
2.45B
2.04B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
248.51M
241.28M
276.18M
280.38M
Operating expense
713.95M
715.86M
1.04B
968.16M
Total operating expenses
2.04B
2.15B
3.49B
3.01B
Operating income
-103.77M
-74.65M
192.56M
30.51M
Other non operating income
107.74M
56.09M
77.74M
18.28M
EBT including unusual items
-57.24M
-126.14M
258.41M
32.97M
EBT excluding unusual items
-57.24M
-55.01M
260.61M
32.97M
Income tax expense
-
-
17.00K
723.00K
Effective tax rate
-
-
0.01%
2.19%
Other operating expenses
376.43M
384.29M
651.12M
578.29M
Net income
-57.24M
-126.14M
258.39M
32.24M
Net profit margin
-2.96%
-6.09%
7.02%
1.06%
Earnings per share
-1.13
-1.08
4.58
0.54
Interest and investment income
-
-
-
-
Interest expense
-37.32M
-31.78M
-19.64M
-22.30M
Net interest expenses
-37.32M
-31.78M
-19.64M
-22.30M
Depreciation and amortization charges
89.01M
90.29M
109.03M
109.49M
EBITDA
-15.99M
10.45M
281.20M
119.14M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps